Boardroom Alpha
Start trial
10-K/A primary document
ICCC · Amended Annual Report (Form 10-K/A) · Filed May 13, 2026

Immucell Corp — 10-K/A exhibit

ex_957645.htm
Immucell Corp on Boardroom Alpha
ex_957645.htm

Exhibit 31.1

 

CERTIFICATION PURSUANT TO REQUIRED BY RULE 13a-14(a)

 

I, Paul Olivier te Boekhorst, certify that:

 

1.

I have reviewed this Annual Report on Form 10-K/A [Amendment No. 1] of ImmuCell Corporation (the Company);

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

[Because this Amendment does not include or amend any financial statements or financial information, paragraphs 3, 4, and 5 of this certification have been omitted.]

 

Date: May 13, 2026

 

/s/ Paul Olivier te Boekhorst

  
Paul Olivier te Boekhorst  

President and Chief Executive Officer

  

 

 
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer